v3.26.1
Net Loss Per Share
6 Months Ended 12 Months Ended
Jun. 30, 2026
Dec. 31, 2025
Net Loss Per Share [Abstract]    
Net Loss per Share

11. Net Loss per Share

The following table sets forth the computation of net loss per common share (in thousands except share and per share amounts):

 

Six Months Ended
June 30

   

2026

 

2025

Net loss per share

 

 

 

 

 

 

 

 

Numerator

 

 

 

 

 

 

 

 

Net loss

 

$

(9,610

)

 

$

(5,645

)

Numerator for basic and diluted net loss per share

 

$

(9,610

)

 

$

(5,645

)

 

Six Months Ended
June 30

   

2026

 

2025

Denominator

 

 

 

 

 

 

 

 

Weighted average common shares outstanding

 

 

10,684,069

 

 

 

10,613,166

 

Denominator for basic and diluted loss per share

 

 

10,684,069

 

 

 

10,613,166

 

   

 

 

 

 

 

 

 

Net loss per share

 

 

 

 

 

 

 

 

Basic and diluted

 

$

(0.90

)

 

$

(0.53

)

The Company’s convertible preferred stock are participating securities, which requires the application of the two-class method to calculate basic and diluted earnings per share. The two-class method does not apply during periods of net loss since preferred stockholders are not contractually obligated to share in net losses of the Company. Accordingly, no allocation of net loss was made to preferred stockholders during the six months ended June 30, 2026 and 2025.

The Company’s potentially dilutive securities, which include convertible preferred stock and stock options to purchase common stock, have been excluded from the computations of diluted net loss per share as the effect would be antidilutive. Therefore, the weighted average number of common shares outstanding used to calculate both basic and diluted net loss per share is the same. The Company excluded the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share for the periods indicated because including them would have had an anti-dilutive effect:

 

Six Months Ended
June 30,

   

2026

 

2025

Series Seed-1 (as converted to common stock)

 

1,536,006

 

1,536,006

Series Seed-2 (as converted to common stock)

 

1,099,412

 

1,099,412

Series A-1 (as converted to common stock)

 

1,059,058

 

1,059,058

Series A (as converted to common stock)

 

2,652,734

 

2,652,734

Series SA-2 (as converted to common stock)

 

1,745,625

 

1,745,625

Series A-2 (as converted to common stock)

 

3,184,572

 

3,184,572

Series X (as converted to common stock)

 

779,240

 

Stock options to purchase common stock

 

3,256,084

 

3,362,773

Unvested restricted common stock

 

809,464

 

   

16,122,195

 

14,640,180

13. Net Loss per Share

The following table sets forth the computation of net loss per common share (in thousands except share and per share amounts):

 

Year ended December 31

   

2025

 

2024

Net loss per share

 

 

 

 

 

 

 

 

Numerator

 

 

 

 

 

 

 

 

Net loss

 

$

(12,199

)

 

$

(10,065

)

Numerator for basic and diluted net loss per share

 

$

(12,199

)

 

$

(10,065

)

   

 

 

 

 

 

 

 

Denominator

 

 

 

 

 

 

 

 

Weighted average common shares outstanding

 

 

10,638,595

 

 

 

10,575,252

 

Denominator for basic and diluted loss per share

 

 

10,638,595

 

 

 

10,575,252

 

   

 

 

 

 

 

 

 

Net loss per share

 

 

 

 

 

 

 

 

Basic and diluted

 

$

(1.15

)

 

$

(0.95

)

The Company’s convertible preferred stock are participating securities, which requires the application of the two-class method to calculate basic and diluted earnings per share. The two-class method does not apply during periods of net loss since preferred stockholders are not contractually obligated to share in net losses of the Company. Accordingly, no allocation of net loss was made to preferred stockholders during the years ended December 31, 2025 and 2024.

The Company’s potentially dilutive securities, which include convertible preferred stock and stock options to purchase common stock, have been excluded from the computations of diluted net loss per share as the effect would be antidilutive. Therefore, the weighted average number of common shares outstanding used to calculate both basic

and diluted net loss per share is the same. The Company excluded the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share for the periods indicated because including them would have had an anti-dilutive effect:

 

Year ended December 31,

   

2025

 

2024

Series Seed-1 (as converted to common stock)

 

1,536,006

 

1,536,006

Series Seed-2 (as converted to common stock)

 

1,099,412

 

1,099,412

Series A-1 (as converted to common stock)

 

1,059,058

 

1,059,058

Series A (as converted to common stock)

 

2,652,734

 

2,652,734

Series SA-2 (as converted to common stock)

 

1,745,625

 

1,745,625

Series A-2 (as converted to common stock)

 

3,184,572

 

1,773,460

Series X (as converted to common stock)

 

769,114

 

Stock options to purchase common stock

 

3,307,849

 

1,617,266

Unvested restricted common stock

 

329,104

 

   

15,683,474

 

11,483,561